Latest AI and machine learning research in other cancers for healthcare professionals.
PURPOSE: This study aimed to develop a deep learning (DL) model based on three-dimensional multi-par...
Metastatic tumors of the head and neck (MTHN) typically indicate advanced disease with a poor progno...
No robust biomarkers have been identified to predict the efficacy of programmed cell death protein ...
AIM: This study aimed to develop and validate a deep learning radiomics nomogram (DLRN) derived from...
We introduce an artificial intelligence model to personalize treatment in major depression, which wa...
BACKGROUND: Protein palmitoylation is a reversible post-translational modification that increases pr...
RATIONALE AND OBJECTIVES: To explore the value of machine learning models based on MRI radiomics and...
This study presents an integrated approach combining hyperspectral imaging (HSI) and deep learning f...
Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions of the gastrointestin...
Endoscopic submucosal dissection (ESD) enables en-bloc resection of large lesions more than 20 mm in...
BACKGROUND: Breast cancer is the most prevalent malignancy in women and a leading cause of mortality...
Liver cancer, including hepatocellular carcinoma (HCC), cholangiocellular carcinoma (CCC), and metas...
AIMS: To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TIL...
Approximately 70% of breast cancer (BC) diagnoses are estrogen receptor positive (ER) with ∼40% of E...
Liver cancer remains a significant global health concern, ranking as the sixth most common malignanc...
Breast cancer significantly affects people's health globally, making early and accurate diagnosis vi...
BACKGROUND: Diagnosing the presence of metastasis of pancreatic cancer is pivotal for patient manage...
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor, with ri...
Vaccines have had a major impact on the control of infectious disease, most recently by helping to c...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet the response rate rema...
Immune dysregulation and metabolism reprogramming are implicated in bladder cancer (BLCA), the relat...